BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3047214)

  • 1. Influence of oral cimetidine and ranitidine on gastric emptying in active duodenal ulcer.
    Jonderko K
    J Clin Gastroenterol; 1988 Apr; 10(2):143-9. PubMed ID: 3047214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ranitidine and cimetidine on gastric emptying of a mixed meal in man.
    Corinaldesi R; Scarpignato C; Galassi A; Stanghellini V; Calamelli R; Bertaccini G; Barbara L
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):498-501. PubMed ID: 6094367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.
    Gledhill T; Howard OM; Buck M; Paul A; Hunt RH
    Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of peptic ulcer with ranitidine and cimetidine in a single nocturnal dose].
    Klinger J; Maggiolo P; Arteaga H; Goić A
    Rev Med Chil; 1987 Jul; 115(7):645-7. PubMed ID: 3331025
    [No Abstract]   [Full Text] [Related]  

  • 5. Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing.
    Khasawneh SM; Affarah HB
    Am J Gastroenterol; 1992 Sep; 87(9):1180-2. PubMed ID: 1519576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Does nocturnal monitoring of gastric pH permit the prediction of therapeutic response in severe duodenal ulcer treated with ranitidine?].
    Galmiche JP; Tranvouez JL; Denis P; N'Djitoyap C; Guillard JF; Lehur PA; Colin R
    Gastroenterol Clin Biol; 1985; 9(8-9):583-9. PubMed ID: 4076717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocturnal gastric acid secretion: its importance in the pathophysiology and rational therapy of duodenal ulcer.
    De Gara CJ; Gledhill T; Hunt RH
    Scand J Gastroenterol Suppl; 1986; 121():17-24. PubMed ID: 3532294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large single daily dose of histamine H2 receptor antagonist for duodenal ulcer. How much and when? A clinical pharmacological study.
    Deakin M; Glenny HP; Ramage JK; Mills JG; Burland WL; Williams JG
    Gut; 1987 May; 28(5):566-72. PubMed ID: 3596338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dosage and effectiveness of cimetidine and ranitidine in the treatment of duodenal ulcer].
    Nowak A; Gibiński K
    Pol Tyg Lek; 1984 Jun; 39(23):789-91. PubMed ID: 6093081
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of gastric emptying rate after cimetidine and ranitidine measured by applied potential tomography.
    Mushambi MC; Trotter TN; Barker P; Rowbotham DJ
    Br J Clin Pharmacol; 1992 Sep; 34(3):278-80. PubMed ID: 1389955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of ranitidine and cimetidine in the treatment of gastric or duodenal ulcer resistant to an initial treatment with cimetidine. Multicenter controlled therapeutic trial].
    Amouretti M; Ansenay M; Bader JP; Baillet J; Bel A; Belaïche J; Benzenou A; Bertrand G; Bonfils S; Boucekkine T
    Gastroenterol Clin Biol; 1985 Feb; 9(2):147-52. PubMed ID: 3884426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of 'cimetidine-resistant' chronic duodenal ulcers with ranitidine or cimetidine: a randomised multicentre study.
    Quatrini M; Basilisco G; Bianchi PA
    Gut; 1984 Oct; 25(10):1113-7. PubMed ID: 6090280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind randomized study comparing different dose regimens of H2-receptor antagonists on 24-hour gastric secretion in normal subjects and duodenal ulcer patients.
    de Gara CJ; Burget DW; Silletti C; Hunt RH
    Am J Gastroenterol; 1987 Jan; 82(1):36-41. PubMed ID: 3099564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastric emptying in patients with duodenal peptic ulcer before and after H2 blockader therapy].
    Usai P; Piga M; Satta L; Vincis R; Loi G; Balestrieri A
    Minerva Dietol Gastroenterol; 1985; 31(2):113-6. PubMed ID: 4034015
    [No Abstract]   [Full Text] [Related]  

  • 16. Intragastric pH monitoring in acute upper gastrointestinal bleeding and the effect of intravenous cimetidine and ranitidine.
    Reynolds JR; Walt RP; Clark AG; Hardcastle JD; Langman MJ
    Aliment Pharmacol Ther; 1987 Feb; 1(1):23-30. PubMed ID: 2979209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is gastric emptying abnormal in duodenal ulcer?
    Holt S; Heading RC; Taylor TV; Forrest JA; Tothill P
    Dig Dis Sci; 1986 Jul; 31(7):685-92. PubMed ID: 3720465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous cimetidine or two regimens of ranitidine to reduce fasting gastric acidity.
    Peterson WL; Richardson CT
    Ann Intern Med; 1986 Apr; 104(4):505-7. PubMed ID: 3954278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily gastric pH in controls and in duodenal ulcer patients: basal condition and response to treatment.
    Masoero G; Rossanino A; Arossa W; Marchetto M; Marucci M; De la Pierre M
    Am J Gastroenterol; 1988 Feb; 83(2):136-42. PubMed ID: 3341336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ranitidine and cimetidine in 2 daily doses, in the short-term treatment of duodenal ulcer].
    Medina LA; Palacios A; Fuster F; Avendaño S
    Rev Med Chil; 1984 May; 112(5):457-62. PubMed ID: 6095389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.